{"id":4822,"date":"2023-07-25T14:57:53","date_gmt":"2023-07-25T14:57:53","guid":{"rendered":"https:\/\/wapcpharm.org\/journal\/?p=4822"},"modified":"2023-08-02T15:14:20","modified_gmt":"2023-08-02T15:14:20","slug":"west-african-journal-of-pharmacy-2016-27-1-78-90","status":"publish","type":"post","link":"https:\/\/wapcpharm.org\/journal\/west-african-journal-of-pharmacy-2016-27-1-78-90\/","title":{"rendered":"West African Journal of Pharmacy (2016) 27 (1) 78-90"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Assessment of quality assurance capability for medicines in community pharmacies in two cities in Nigeria<\/b><\/p>

\u00a0<\/p>

Omoniyi J. Ola-Olorun and Akeem A. Tijani<\/p>

\u00a0<\/p>

Department of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy,\u00a0Obafemi Awolowo University, Ile-Ife. Osun State. Nigeria.<\/span><\/p>

\u00a0<\/span><\/p>

Corresponding author: Omoniyi J. Ola-Olorun<\/p>

Email: niyiolaolorun@gmail.com Phone: +2348034119314<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

ABSTRACT<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Background: <\/b>Medicine quality is a global concern and lack of reliable quality assurance (QA) system for medicines may be contributory to the high level of spurious medicines in many developing countries.<\/span><\/p>

Objectives:<\/b> The study evaluated the level of institutionalization of QA components for medicine inventory in community pharmacies in two cities of Osun State in Nigeria as a measure of QA capability and explored for <\/span>factors influencing QA capability.<\/span><\/p>

Methods:<\/b> A set of pretested semi-structured questionnaire was administered to community pharmacists practicing in Oshogbo and Ile-Ife. The instrument sought information on the level of institutionalization of <\/span>essential components of QA, and explored for factors influencing QA, both on ordinal scales with weighting <\/span>scores of 1-5 and 0-4 respectively. Descriptive statistics were used to summarize the data. Chi square, <\/span>Spearman’s rank correlation as well as multiple and ordinal regressions were used to evaluate the <\/span>respondents’ opinions at 5% level of significance.<\/span><\/p>

Results:<\/b> Only two (12.5%) of the essential components of QA had been implemented (WA\u2248 4) and none institutionalised (WA\u2248 5). The three most prominent factors influencing QA capability were management <\/span>commitment, suppliers and government regulatory control all with median score of 4.<\/span><\/p>

Conclusion:<\/b> Quality assurance capability for medicine inventory in the community pharmacies was low.<\/p>

Key words:<\/b> Medicine quality, counterfeit medicine, quality assurance, quality assurance capability, community pharmacy.<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\tDownload <\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Assessment of quality assurance capability for medicines in community pharmacies in two cities in Nigeria \u00a0 Omoniyi J. Ola-Olorun and Akeem A. Tijani \u00a0 Department of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy,\u00a0Obafemi Awolowo University, Ile-Ife. Osun State. Nigeria. \u00a0 Corresponding author: Omoniyi J. Ola-Olorun Email: niyiolaolorun@gmail.com Phone: +2348034119314 ABSTRACT Background: Medicine quality is […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[226],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4822"}],"collection":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/comments?post=4822"}],"version-history":[{"count":4,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4822\/revisions"}],"predecessor-version":[{"id":4828,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4822\/revisions\/4828"}],"wp:attachment":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/media?parent=4822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/categories?post=4822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/tags?post=4822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}